Literature DB >> 2158878

Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS.

P R Miles1, R P Baughman, C C Linnemann.   

Abstract

This study investigated the significance of detecting cytomegalovirus in the bronchoalveolar lavage fluid of patients with human immunodeficiency virus infection. Bronchoscopy with BAL was performed on all patients. Lavage was examined for CMV by cytology, culture, and immunofluorescence. The lavage results were compared to clinical status at the time of bronchoscopy and the outcome of the respiratory event. Cytomegalovirus was detected in 51 percent of the BALs in the patients with HIV infection and 25 percent of the immunosuppressed patients without HIV. No association was found in the HIV infected patients between CMV and hypoxemia, abnormal chest roentgenogram, leukopenia, and increased mortality. As indicated by mortality, CMV did not significantly increase the severity of Pneumocystis carinii pneumonia. The study also suggested that CMV in BAL fluid reflected bronchopulmonary replication of the virus, and not contamination by virus in the blood. Cytomegalovirus does not appear to contribute directly to the pulmonary disease found in most patients with HIV infection.

Entities:  

Mesh:

Year:  1990        PMID: 2158878     DOI: 10.1378/chest.97.5.1072

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

Review 1.  The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia.

Authors:  R J Boyton; D M Mitchell; O M Kon
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 2.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

3.  Use of bronchoscopy in the diagnosis of infection in the immunocompromised host.

Authors:  R P Baughman
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

Review 4.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

Review 5.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

6.  Severe cytomegalovirus pneumonitis in HIV infected patients with higher than average CD4 counts.

Authors:  S B Squire; M C Lipman; E K Bagdades; P M Mulvenna; J E Grundy; P D Griffiths; M A Johnson
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 7.  Clinical review: Respiratory failure in HIV-infected patients--a changing picture.

Authors:  Putul Sarkar; Husham F Rasheed
Journal:  Crit Care       Date:  2013-06-14       Impact factor: 9.097

8.  The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia.

Authors:  Chung-Wei Chou; Fang-Chi Lin; Han-Chen Tsai; Shi-Chuan Chang
Journal:  BMC Pulm Med       Date:  2014-11-19       Impact factor: 3.317

9.  Clinical applications of interferon-γ releasing assays for cytomegalovirus to differentiate cytomegalovirus disease from bystander activation: a pilot proof-of-concept study.

Authors:  Sung-Han Kim; Ho-Su Lee; Hyun-Jung Lee; Sun-Mi Kim; Sung Shin; Sang-Hyoung Park; Kyung-Jo Kim; Young-Hoon Kim; Heungsup Sung; Sang-Oh Lee; Sang-Ho Choi; Suk-Kyun Yang; Yang Soo Kim; Jun Hee Woo; Duck-Jong Han
Journal:  Korean J Intern Med       Date:  2017-08-23       Impact factor: 2.884

10.  Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.

Authors:  Qing Yu; Peng Jia; Li Su; Hong Zhao; Chengli Que
Journal:  BMC Infect Dis       Date:  2017-06-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.